|
|
|
|
|
| |
|
| Title: |
Continuity of Care in Pulmonary Arterial Hypertension |
| Date: |
Wednesday, June 18, 2008 |
| Time: |
11:45 AM - 01:30 PM |
| Type: |
SYMP-LUNCH  |
| Level: |
- |
| Track: |
- |
| Sponsor(s): |
|
| Speaker(s): |
Sandra Lombardi |
|
Pulmonary arterial hypertension (PAH) is defined by increased pressure on the arterial side of pulmonary circulation. It is estimated that ~80,000 patients in the US have PAH, most of whom are undiagnosed. The exact pathologic mechanisms of disease are unknown, but it is widely accepted that PAH is a multifactorial condition, involving both genetic and environmental conditions. Without intervention, the clinical course of PAH is grave. Typical signs and symptoms are often subtle and nonspecific, making diagnosis difficult. The three major drug classes used in the treatment of PAH are prostanoids, endothelin-receptor antagonists, and phosphodiesterase-5 inhibitors. Adjunctive therapy is also often employed, and surgery is an option for patients with severe disease. PAH is a complex disease requiring a multimodal approach to management, and therefore, the case manager is critical in ensuring coordination of care between the various healthcare professionals, the patient’s support system, third-party payers, and the patient.
Objectives:
- Define PAH and discuss the appropriate diagnostic criteria and what conditions need to be ruled out during the diagnostic evaluation.
- Discuss current and future treatment options for PAH and the associated risk-benefit profile of each treatment option.
- Discuss the multidisciplinary approach to treating patients with PAH.
|
|
|
This symbol indicates that attendance to this catered symposia program, pre- or post-conference workshop is limited and requires a ticket for admission. Register for these sessions early to ensure admission to the programs of your choice. Sessions have limited seating availability and pre-registration for each of these programs is on a first-come, first-served basis. If seating is still available, unticketed attendees may enter the session 15-minutes after the session starts.
|
|
|